Artificial Ventilation and Anesthesia Masks Market Report 2025

The artificial ventilation and anesthesia masks market size has grown strongly in recent years. It will grow from $2.18 billion in 2024 to $2.32 billion in 2025 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to an increasing number of surgical procedures, rising prevalence of chronic obstructive pulmonary disease (COPD), higher admissions to intensive care units, growing awareness of respiratory health, and an expanding geriatric population.

The artificial ventilation and anesthesia masks market size is expected to see strong growth in the next few years. It will grow to $2.99 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to increasing demand for outpatient surgical procedures, rising investments in healthcare infrastructure, growing adoption of home healthcare ventilation solutions, an expanding geriatric population, and increased utilization of emergency medical services. Major trends in the forecast period include advancements in anesthesia mask materials, integration with patient monitoring systems, innovations in pediatric and ergonomic designs, ongoing research and development in ventilation devices, and the growth of single-use and disposable technologies.

The rising incidence of respiratory diseases is expected to propel the growth of the artificial ventilation and anesthesia mask market going forward. Respiratory diseases refer to conditions affecting the lungs, airways, and respiratory muscles, such as asthma, bronchitis, and chronic obstructive pulmonary disease (COPD). The prevalence of these diseases is increasing due to prolonged exposure to air pollution, including fine particulate matter and toxic gases, which damage lung tissue and trigger inflammation. Artificial ventilation and anesthesia masks aid in managing respiratory diseases by delivering precise oxygen or anesthetic gases during surgeries, intensive care, or emergencies, maintaining stable respiratory function. For instance, in June 2025, according to the Office for Health Improvement and Disparities in the UK, emergency admissions for respiratory diseases in England increased by 7% between 2023 and 2024, including a 9% rise for COPD, 17% for adult asthma, and 16% for pneumonia. Therefore, the rising incidence of respiratory diseases is driving the growth of the artificial ventilation and anesthesia mask market.

The rising number of surgeries is also expected to propel market growth. Surgical procedures involve cutting or manipulating internal structures to diagnose, treat, or correct health conditions. The number of surgeries is increasing due to safer, less invasive, and more effective surgical technologies, which encourage more patients to undergo procedures. Artificial ventilation and anesthesia masks are essential in surgeries, ensuring proper breathing and delivery of anesthetic gases to maintain patient safety. For example, in September 2023, according to the International Society of Aesthetic Plastic Surgery, over 14.9 million surgical and 18.8 million non-surgical procedures were performed globally in 2022, reflecting an overall increase of 11.2%.

In February 2025, GaleMed Corporation, a Taiwan-based manufacturer of respiratory and anesthesia consumables, partnered with Israel-based Inspir Labs to launch the Lumena mask. The collaboration aims to enhance non-invasive ventilation safety by reducing aerosol dispersion and protecting patients and healthcare workers worldwide.

Major players in the artificial ventilation and anesthesia masks market are Cardinal Health Inc., Air Liquide Medical Systems S.A., Medtronic plc, Koninklijke Philips N.V., GE Healthcare Technologies Inc., ResMed Inc., Teleflex Incorporated, Getinge AB, Fisher & Paykel Healthcare Corporation Limited, Drägerwerk AG & Co. KGaA, Ambu A/S, Hamilton Medical AG, GaleMed Corporation, Armstrong Medical Ltd., Cathwide Medical Inc., Romsons Scientific and Surgical Industries Pvt. Ltd., Trudell Medical International, Besmed Health Business Corporation, Flexicare Medical Limited, Intersurgical Ltd., O-Two Medical Technologies Inc., and Hans Rudolph Inc.

North America was the largest region in the artificial ventilation and anesthesia masks market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in artificial ventilation and anesthesia masks market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the artificial ventilation and anesthesia masks market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

Artificial ventilation and anesthesia masks are medical devices designed to cover a patient’s nose and mouth, providing a sealed interface for the controlled delivery of oxygen, ambient air, or anesthetic gases during medical procedures. These masks are essential for supporting or fully managing a patient’s breathing, especially during surgeries, intensive care, or emergency interventions, ensuring respiratory stability and patient safety.

The key types of artificial ventilation and anesthesia masks are invasive ventilation masks and non-invasive ventilation masks. Invasive ventilation involves delivering air to the lungs through a tube inserted into the patient’s trachea, commonly via an endotracheal or tracheostomy tube. This category includes disposable and reusable masks and serves various end users, including operating rooms, intensive care units, emergency rooms, homecare, and ambulatory surgical centers.

The artificial ventilation and anesthesia masks market research report is one of a series of new reports that provides artificial ventilation and anesthesia masks market statistics, including artificial ventilation and anesthesia masks industry global market size, regional shares, competitors with an artificial ventilation and anesthesia masks market share, detailed artificial ventilation and anesthesia masks market segments, market trends and opportunities, and any further data you may need to thrive in the artificial ventilation and anesthesia masks industry. This artificial ventilation and anesthesia masks market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The artificial ventilation and anesthesia masks market consists of sales of disposable anesthesia masks, reusable anesthesia masks, continuous positive airway pressure (CPAP) masks, bilevel positive airway pressure (BiPAP) masks, and high-flow oxygen masks. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.